Helexva
About:
Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.
Top Investors: UPMC Enterprises
Description:
Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.
Total Funding Amount:
$2.25M
Headquarters Location:
Pittsburgh, Pennsylvania, United States
Founded Date:
2023-01-01
Founders:
Number of Employees:
Last Funding Date:
2024-03-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai